Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$82.84 - $88.09 $187,798 - $199,700
2,267 Added 4.66%
50,940 $4.44 Million
Q4 2023

Feb 02, 2024

BUY
$69.43 - $83.43 $118,447 - $142,331
1,706 Added 3.63%
48,673 $4.01 Million
Q3 2023

Nov 08, 2023

BUY
$78.22 - $90.4 $164,731 - $190,382
2,106 Added 4.69%
46,967 $3.68 Million
Q2 2023

Aug 14, 2023

BUY
$79.47 - $91.38 $69,854 - $80,323
879 Added 2.0%
44,861 $3.95 Million
Q1 2023

May 04, 2023

BUY
$76.72 - $87.58 $789,065 - $900,760
10,285 Added 30.52%
43,982 $3.55 Million
Q4 2022

Feb 10, 2023

BUY
$76.18 - $87.74 $2.57 Million - $2.96 Million
33,697 New
33,697 $2.62 Million
Q4 2021

Feb 11, 2022

SELL
$99.53 - $127.75 $49,466 - $63,491
-497 Closed
0 $0
Q3 2021

Nov 17, 2021

BUY
$122.75 - $135.17 $61,006 - $67,179
497 New
497 $62,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Consolidated Planning Corp Portfolio

Follow Consolidated Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consolidated Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Consolidated Planning Corp with notifications on news.